{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-21-148608","form_type":"8-K","ticker":"ABT","cik":"0000001800","company_name":"ABBOTT LABORATORIES","filed_at":"2021-12-10T23:59:59+00:00","discovered_at":"2026-05-14T18:04:14.202069+00:00","generated_at":"2026-06-28T02:08:42.638598+00:00","sec_items":["5.02","5.03","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Abbott names CEO Robert B. Ford as Chairman; Miles D. White retires","bullets":["Miles D. White resigns as Executive Chairman and director, effective Dec 10, 2021.","CEO Robert B. Ford appointed Chairman of the Board, effective same date.","White retires after 38 years at Abbott; led transformation into health tech leader.","Board size reduced from 14 to 13; by-laws amended for remote shareholder meetings."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-21-148608","json":"https://secwatch.observer/filing/0001104659-21-148608.json","markdown":"https://secwatch.observer/filing/0001104659-21-148608.md","text":"https://secwatch.observer/filing/0001104659-21-148608.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1800/000110465921148608/0001104659-21-148608-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1800/000110465921148608/tm2134920d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T02:08:42.638598+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1c272b2544","claim":"Robert B. Ford was appointed as Chairman of the Board at ABBOTT LABORATORIES.","evidence_excerpt":"On December 10, 2021, Abbott’s Board of Directors appointed Robert B. Ford, Abbott’s President and Chief Executive Officer and a director, to the additional position of Chairman of the Board, effective upon Mr. White’s resignation.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1800/000110465921148608/0001104659-21-148608-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chairman of the Board"}],"fact_type":"executive_change"},{"claim_id":"d8b793e6d6","claim":"Miles D. White departed as Executive Chairman at ABBOTT LABORATORIES.","evidence_excerpt":"Miles D. White informed the Abbott Laboratories (“Abbott”) Board of Directors that he will step down as Executive Chairman of the Board and as a director, effective December 10, 2021.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1800/000110465921148608/0001104659-21-148608-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"stepped down"},{"label":"Role","value":"Executive Chairman"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}